Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 5/2008

01-05-2008 | Research Articles

Randomised study of single dose (8 Gy vs. 6 Gy) of analgesic radiotherapy plus zoledronic acid in patients with bone metastases

Authors: Ana Mañas, Francesc Casas, Juan P. Ciria, Concha López, Juan Sáez, Amalia Palacios, Manuel de las Heras, Carmen Porto, Elena Sánchez, Carmen Martín, Ricardo Esco, Camilo Veiras, José C. Martínez, Magdalena Márquez, Alfedo Ramos, Felipe Calvo, Javier Fuertes, Francisco J. Andreu, Jorge Contreras, Leopoldo Pérez, Jesús Romero, Jordi Vayreda, Concepción Victoria

Published in: Clinical and Translational Oncology | Issue 5/2008

Login to get access
Metadata
Title
Randomised study of single dose (8 Gy vs. 6 Gy) of analgesic radiotherapy plus zoledronic acid in patients with bone metastases
Authors
Ana Mañas
Francesc Casas
Juan P. Ciria
Concha López
Juan Sáez
Amalia Palacios
Manuel de las Heras
Carmen Porto
Elena Sánchez
Carmen Martín
Ricardo Esco
Camilo Veiras
José C. Martínez
Magdalena Márquez
Alfedo Ramos
Felipe Calvo
Javier Fuertes
Francisco J. Andreu
Jorge Contreras
Leopoldo Pérez
Jesús Romero
Jordi Vayreda
Concepción Victoria
Publication date
01-05-2008
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 5/2008
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-008-0198-5

Other articles of this Issue 5/2008

Clinical and Translational Oncology 5/2008 Go to the issue

Educational Series

Cancer stem cells and brain tumors

Case Reports

Successful rectal cancer local recurrence radiofrequency ablation

Editorial

A continued progression of FESEO’s Journal

Case Reports

Primary neuroendocrine small cell undifferentiated carcinoma of the parotid gland

Leaders in Spanish Oncology

An interview with Nicolás Díaz Chico, president of the Spanish Association for Cancer Research (ASEICA)

Reviews

Screening and chemoprevention in lung cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits